102
Participants
Start Date
August 1, 2024
Primary Completion Date
July 31, 2025
Study Completion Date
July 31, 2025
Brivaracetam
Brivaracetam was initiated at a dose of 1-2 mg/kg/day in two divided doses, titrated to a maximum of 5 mg/kg/day based on clinical response and tolerability.
Levetiracetam
Levetiracetam was initiated at a dose of 10-20 mg/kg/day in two divided doses, with gradual escalation up to 60 mg/kg/day if needed.
The Children's Hospital and Institute of Child Health, Multan
RESnTEC, Institute of Research
OTHER